Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Bremelanotide (Vyleesi) vs Histrelin (Supprelin LA / Vantas)
An educational, source-based comparison of Bremelanotide (Vyleesi) and Histrelin (Supprelin LA / Vantas) — how each peptide works, what it's researched for, and what to know before going deeper.
Melanocortin receptor agonist for hypoactive sexual desire disorder in premenopausal women.
Cyclic 7-amino-acid synthetic analog of α-MSH that activates melanocortin receptors (primarily MC4R) in the CNS, modulating sexual desire pathways.
- Acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women
- • FDA-approved.
- • Nausea, flushing, transient BP elevation common.
GnRH agonist implant for central precocious puberty and prostate cancer.
Synthetic nonapeptide GnRH agonist delivered via a subcutaneous hydrogel implant providing continuous release for 12 months, desensitizing the pituitary and suppressing sex steroids.
- Central precocious puberty (Supprelin LA)
- Advanced prostate cancer (Vantas)
- • FDA-approved.
- • Implant site reactions and rare implant breakage at removal.
Bremelanotide (Vyleesi) vs Histrelin (Supprelin LA / Vantas) — Key differences
- Class: Bremelanotide (Vyleesi) is classified as Melanocortin Agonist · Sexual Health, while Histrelin (Supprelin LA / Vantas) is GnRH Agonist · Endocrine.
- Primary research focus: Bremelanotide (Vyleesi) — acquired, generalized hypoactive sexual desire disorder (hsdd) in premenopausal women; Histrelin (Supprelin LA / Vantas) — central precocious puberty (supprelin la).
- Tag: FDA-Approved · Sexual Health vs FDA-Approved · Endocrine.